The “Business” of Drugs: New Study of 2 Million People Confirms Dangerous side Effects of Cholesterol Drugs

The "Business" of Drugs: New Study

The "Business" of Drugs: New Study

Dear Members,
In a study monitoring more than 2 million people in Britain, researchers from Nottingham University found that adverse side effects of cholesterol lowering drugs, known as “statins,” were generally consistent and worse in the first year of treatment.
Referring to the study earlier this week Reuters News Service reported that people using cholesterol-lowering statins have a higher risks of liver dysfunction, kidney failure, muscle weakness and cataracts and such side effects of the drug should be closely tracked, doctors said on Friday.
See Reuters report:
In fact, the study, published in the British Medical Journal, said patients taking statins like Pfizer’s Lipitor and AstraZeneca’s Crestor should be “proactively monitored” for side effects.
“Our study is likely to be useful for policy and planning purposes,” said Julia Hippisley-Cox and Carol Coupland, the two professors who led the study. They said it may also be useful “for informing guidelines on the type and dose of statins.”
Ironically, statins are among the most financially successful drugs of all time yet heart disease continues to be the leading and growing killer of men and women throughout the world. 
Coupland and Hippisley-Cox studied data from 368 general practices on 2,004,692 patients aged 30-84 years including 225,922 patients who were new statin users and had been prescribed a range of statins. They found that for every 10,000 high risk women treated with statins, the positive impact would be around 271 fewer cases of heart disease and 8 fewer cases of oesophageal cancer.
On the other side, there would also be 74 extra patients with liver dysfunction, 23 extra patients with acute renal failure, 307 with cataracts and 39 with a muscle weakness condition called myopathy.
The adverse effects including liver dysfunction, acute renal failure, cataracts and a muscle weakness condition called myopathy, were similar for all different types of statins, except for liver dysfunction, where the highest risks were found for Fluvastatin, which is sold by Novartis under the brand names Lescol and Lochol.
“All of the increased risks persisted during the treatment, but were highest in the first year,” they wrote.
To learn more about the billion dollar cholesterol scam get your copy of Dr. Gottfried Lange’s explosive e-book;
How to Really Prevent and Cure Heart Disease: The Billion Dollar Cholesterol Scam, available through HealthNet Publishing –  www.HealthNetPublishign.Com and Amazon.Com.
All the best,
Rudi C. Loehwing
Managing Director
World Institute of Natural Health Sciences

1 comment so far

  1. sandy on

    your post very interesting.,
    thats all be my inspirations.,
    I hope you will visit my website and please give suggestions and input … thanks
    This my web about Alternative Medicine :

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: